Evidence map›Paper›PMID 30209334›Full record

ArticleScientific reports2018

Interleukin-17D and Nrf2 mediate initial innate immune cell recruitment and restrict MCMV infection.

Ruth Seelige, Robert Saddawi-Konefka, Nicholas M Adams, Gaëlle Picarda, Joseph C Sun, Chris A Benedict, Jack D Bui

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
2.0field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 31 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Review
  5. Article
  6. NRF2 in Viral Infection.Antioxidants (Basel, Switzerland) · 2021
    Review
  7. Article
  8. Review
  9. Article
  10. Evaluation of IL-17D in Host Immunity to Group AJournal of immunology (Baltimore, Md. : 1950) · 2020
    Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Review
  17. The Potential Role of Nrf2 Signaling in Leishmania Infection Outcomes.Frontiers in cellular and infection microbiology · 2019
    Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 1 country.

Ruth SeeligeDepartment of Pathology, University of California, San Diego, CA, 92093, USA.
Robert Saddawi-KonefkaDepartment of Pathology, University of California, San Diego, CA, 92093, USA.
Nicholas M AdamsImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.ORCID 0000-0001-5751-0480
Gaëlle PicardaDivision of Immune Regulation, La Jolla Institute for Allergy and Immunology, La Jolla, CA, 92037, USA.
Joseph C SunImmunology Program, Memorial Sloan Kettering Cancer Center, New York, NY, 10065, USA.ORCID 0000-0001-8062-9033
Chris A BenedictDivision of Immune Regulation, La Jolla Institute for Allergy and Immunology, La Jolla, CA, 92037, USA.
Jack D BuiDepartment of Pathology, University of California, San Diego, CA, 92093, USA. jbui@ucsd.edu.ORCID 0000-0002-9324-368X
University of California San Diego · USLa Jolla Institute for Immunology · USMemorial Sloan Kettering Cancer Center · US

Funding

X-RAY CRYSTALLOGRAPHYP30CA008748 · NCI · SLOAN-KETTERING INSTITUTE FOR CANCER RES · PI Hongbiao Carl Lekaye · 1985 to 2026
$347.4M
Weill Cornell/Rockefeller/Sloan-Kettering MST ProgramT32GM007739 · NIGMS · WEILL MEDICAL COLL OF CORNELL UNIV · PI HSU, KATHARINE C · 1985 to 2023
$51.1M
UCD Mutant Mouse Regional Resource CenterU42OD012210 · OD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI KC KENT LLOYD · 2012 to 2026
$29.2M
The natural killer cell response against mouse cytomegalovirus infectionR01AI100874 · NIAID · SLOAN-KETTERING INST CAN RESEARCH · PI Joseph Chai-Yuen Sun · 2012 to 2026
$7.4M
The role of TRAIL in immune control of cytomegalovirusR01AI101423 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI BENEDICT, CHRISTOPHER A · 2013 to 2023
$4.6M
Innate anti-tumor immune responsesR01CA157885 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI BUI, JACK D · 2011 to 2015
$1.8M
Necroptosis and adaptive immunity to virus infectionR21AI113349 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI BENEDICT, CHRISTOPHER A, UPTON, JASON W · 2016 to 2017
$493k
The role of TRAIL in immune control of cytomegalovirusR56AI101423 · NIAID · LA JOLLA INSTITUTE FOR IMMUNOLOGY · PI BENEDICT, CHRISTOPHER A · 2012 to 2012
$435k
NCI NIH HHS P30 CA008748NCI NIH HHS R01 CA157885NIAID NIH HHS R01 AI100874NIAID NIH HHS R01 AI101423NIAID NIH HHS R21 AI113349NIAID NIH HHS R56 AI101423NIGMS NIH HHS T32 GM007739
6 · The paper itself

Abstract

Innate immune cells quickly infiltrate the site of pathogen entry and not only stave off infection but also initiate antigen presentation and promote adaptive immunity. The recruitment of innate leukocytes has been well studied in the context of extracellular bacterial and fungal infection but less during viral infections. We have recently shown that the understudied cytokine Interleukin (IL)-17D can mediate neutrophil, natural killer (NK) cell and monocyte infiltration in sterile inflammation and cancer. Herein, we show that early immune cell accumulation at the peritoneal site of infection by mouse cytomegalovirus (MCMV) is mediated by IL-17D. Mice deficient in IL-17D or the transcription factor Nuclear factor (erythroid-derived 2)-like 2 (Nrf2), an inducer of IL-17D, featured an early decreased number of innate immune cells at the point of viral entry and were more susceptible to MCMV infection. Interestingly, we were able to artificially induce innate leukocyte infiltration by applying the Nrf2 activator tert-butylhydroquinone (tBHQ), which rendered mice less susceptible to MCMV infection. Our results implicate the Nrf2/IL-17D axis as a sensor of viral infection and suggest therapeutic benefit in boosting this pathway to promote innate antiviral responses.

Indexed as

AnimalsCell Line, TumorEnzyme InhibitorsHerpesviridae InfectionsHydroquinonesImmunity, InnateInterleukin-17Killer Cells, NaturalMiceMice, Inbred BALB CMice, Inbred C57BLMice, KnockoutMuromegalovirusNeutrophilsNF-E2-Related Factor 2RNA Interference2-tert-butylhydroquinoneEnzyme InhibitorsHydroquinonesIl17d protein, mouseInterleukin-17Nfe2l2 protein, mouseNF-E2-Related Factor 2RNA, Small Interfering

Identifiers

PMID30209334
PMCPMC6135835
OpenAlexW2890451178

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.